UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 78

Sortiert nach

Dual Activity Lysophosphatidic Acid Receptor Pan-Antagonist/ Autotaxin Inhibitor Reduces Breast Cancer Cell Migration In vitro and Causes Tumor Regression In vivo

Cancer research (Chicago, Ill.), 2009-07, Vol.69 (13), p.5441-5449

2009

Volltextzugriff (PDF)

Unique Ligand Selectivity of the GPR92/LPA5 Lysophosphatidate Receptor Indicates Role in Human Platelet Activation

The Journal of biological chemistry, 2009-06, Vol.284 (25), p.17304-17319

2009

Volltextzugriff (PDF)

Subtype-specific Residues Involved in Ligand Activation of the Endothelial Differentiation Gene Family Lysophosphatidic Acid Receptors

The Journal of biological chemistry, 2008-05, Vol.283 (18), p.12175-12187

2008

Volltextzugriff (PDF)

Discovery of Ethyl Ketone-Based Highly Selective HDACs 1, 2, 3 Inhibitors for HIV Latency Reactivation with Minimum Cellular Potency Serum Shift and Reduced hERG Activity

Journal of medicinal chemistry, 2021-04, Vol.64 (8), p.4709-4729

2021

Volltextzugriff (PDF)

Identification of free fatty acid receptor 2 agonists using virtual screening

Bioorganic & medicinal chemistry letters, 2020-11, Vol.30 (21), p.127460-127460, Article 127460

2020

Volltextzugriff (PDF)

Informing the Selection of Screening Hit Series with in Silico Absorption, Distribution, Metabolism, Excretion, and Toxicity Profiles

Journal of medicinal chemistry, 2017-08, Vol.60 (16), p.6771

2017

Volltextzugriff (PDF)

Virtual screening for LPA2-specific agonists identifies a nonlipid compound with antiapoptotic actions

Molecular pharmacology, 2012-12, Vol.82 (6), p.1162

2012

Volltextzugriff (PDF)

Workflows and performances in the ranking prediction of 2016 D3R Grand Challenge 2: lessons learned from a collaborative effort

Journal of computer-aided molecular design, 2018, Vol.32 (1), p.129-142

2018

Volltextzugriff (PDF)

Performance of multiple docking and refinement methods in the pose prediction D3R prospective Grand Challenge 2016

Journal of computer-aided molecular design, 2018, Vol.32 (1), p.113-127

2018

Volltextzugriff (PDF)

Mitigation of radiation injury by selective stimulation of the LPA(2) receptor

Biochimica et biophysica acta, 2013-01, Vol.1831 (1), p.117

2013

Volltextzugriff (PDF)

Molecular recognition in the sphingosine 1-phosphate receptor family

Journal of molecular graphics & modelling, 2008-06, Vol.26 (8), p.1189-1201

2008

Volltextzugriff (PDF)

Design and Synthesis of Sulfamoyl Benzoic Acid Analogues with Subnanomolar Agonist Activity Specific to the LPA2 Receptor

Journal of medicinal chemistry, 2014-08, Vol.57 (16), p.7136-7140

2014

Volltextzugriff (PDF)

Informing the Selection of Screening Hit Series with in Silico Absorption, Distribution, Metabolism, Excretion, and Toxicity Profiles: Miniperspective

Journal of medicinal chemistry, 2017-08, Vol.60 (16), p.6771-6780

2017

Volltextzugriff (PDF)

Structure-based drug design identifies novel LPA3 antagonists

Bioorganic & medicinal chemistry, 2009-11, Vol.17 (21), p.7457-7464

2009

Volltextzugriff (PDF)

Targeting the hydrophobic pocket of autotaxin with virtual screening of inhibitors identifies a common aromatic sulfonamide structural motif

The FEBS journal, 2014-02, Vol.281 (4), p.1017-1028

2014

Volltextzugriff (PDF)

Identification of non-lipid LPA3 antagonists by virtual screening

Bioorganic & medicinal chemistry, 2008-06, Vol.16 (11), p.6207-6217

2008

Volltextzugriff (PDF)

Mitigation of radiation injury by selective stimulation of the LPA2 receptor

Biochimica et biophysica acta. Molecular and cell biology of lipids, 2013-01, Vol.1831 (1), p.117-125

2013

Volltextzugriff (PDF)

2D binary QSAR modeling of LPA3 receptor antagonism

Journal of molecular graphics & modelling, 2010-06, Vol.28 (8), p.828-833

2010

Volltextzugriff (PDF)

Combined Mitigation of the Gastrointestinal and Hematopoietic Acute Radiation Syndromes by an LPA2 Receptor-Specific Nonlipid Agonist

Chemistry & biology, 2015-02, Vol.22 (2), p.206-216

2015

Volltextzugriff (PDF)

Design and Synthesis of Sulfamoyl Benzoic Acid Analogues with Subnanomolar Agonist Activity Specific to the LPA 2 Receptor

Journal of medicinal chemistry, 2014-08, Vol.57 (16), p.7136-7140

2014

Volltextzugriff (PDF)

Virtual Screening for LPA 2 -Specific Agonists Identifies a Nonlipid Compound with Antiapoptotic Actions

Molecular pharmacology, 2012-12, Vol.82 (6), p.1162-1173

2012

Volltextzugriff (PDF)

Virtual Screening for LPA2-Specific Agonists Identifies a Nonlipid Compound with Antiapoptotic ActionsS

Molecular pharmacology, 2012-12, Vol.82 (6), p.1162-1173

2012

Volltextzugriff (PDF)

Structure-based drug design identifies novel LPA sub(3) antagonists

Bioorganic & medicinal chemistry, 2009-11, Vol.17 (21), p.7457-7464

2009

Volltextzugriff (PDF)

Structure-based drug design identifies novel LPA 3 antagonists

Bioorganic & medicinal chemistry, 2009, Vol.17 (21), p.7457-7464

2009

Volltextzugriff (PDF)

Combined Mitigation of the Gastrointestinal and Hematopoietic Acute Radiation Syndromes by an LPA 2 Receptor-Specific Nonlipid Agonist

Chemistry & biology, 2015-02, Vol.22 (2), p.206-216

2015

Volltextzugriff (PDF)

1 – 25 von 78

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(63)
Mit Volltextzugriff
(69)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(38)
Life Sciences & Biomedicine
(36)
Humans
(28)
Biochemistry & Molecular Biology
(14)
Chemistry, Medicinal
(12)
Pharmacology & Pharmacy
(12)
Animals
(10)
Chemistry
(10)
Physical Sciences
(10)
Structure-Activity Relationship
(9)
Chemistry, Organic
(8)
Lysophospholipids - Metabolism
(8)
Models, Molecular
(7)
Receptors, Lysophosphatidic Acid - Metabolism
(7)
Binding Sites
(6)
Drug Discovery
(6)
Female
(6)
Ligands
(6)
Molecular Structure
(6)
Adult
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Dual Activity Lysophosphatidic Acid Receptor Pan-Antagonist/ Autotaxin Inhibitor Reduces Breast Cancer Cell Migration In vitro and Causes Tumor Regression In vivo

Unique Ligand Selectivity of the GPR92/LPA5 Lysophosphatidate Receptor Indicates Role in Human Platelet Activation

Subtype-specific Residues Involved in Ligand Activation of the Endothelial Differentiation Gene Family Lysophosphatidic Acid Receptors

Discovery of Ethyl Ketone-Based Highly Selective HDACs 1, 2, 3 Inhibitors for HIV Latency Reactivation with Minimum Cellular Potency Serum Shift and Reduced hERG Activity

Identification of free fatty acid receptor 2 agonists using virtual screening

Informing the Selection of Screening Hit Series with in Silico Absorption, Distribution, Metabolism, Excretion, and Toxicity Profiles

Virtual screening for LPA2-specific agonists identifies a nonlipid compound with antiapoptotic actions

Workflows and performances in the ranking prediction of 2016 D3R Grand Challenge 2: lessons learned from a collaborative effort

Performance of multiple docking and refinement methods in the pose prediction D3R prospective Grand Challenge 2016

Mitigation of radiation injury by selective stimulation of the LPA(2) receptor

Molecular recognition in the sphingosine 1-phosphate receptor family

Design and Synthesis of Sulfamoyl Benzoic Acid Analogues with Subnanomolar Agonist Activity Specific to the LPA2 Receptor

Informing the Selection of Screening Hit Series with in Silico Absorption, Distribution, Metabolism, Excretion, and Toxicity Profiles: Miniperspective

Structure-based drug design identifies novel LPA3 antagonists

Targeting the hydrophobic pocket of autotaxin with virtual screening of inhibitors identifies a common aromatic sulfonamide structural motif

Identification of non-lipid LPA3 antagonists by virtual screening

Mitigation of radiation injury by selective stimulation of the LPA2 receptor

2D binary QSAR modeling of LPA3 receptor antagonism

Combined Mitigation of the Gastrointestinal and Hematopoietic Acute Radiation Syndromes by an LPA2 Receptor-Specific Nonlipid Agonist

Design and Synthesis of Sulfamoyl Benzoic Acid Analogues with Subnanomolar Agonist Activity Specific to the LPA 2 Receptor

Virtual Screening for LPA 2 -Specific Agonists Identifies a Nonlipid Compound with Antiapoptotic Actions

Virtual Screening for LPA2-Specific Agonists Identifies a Nonlipid Compound with Antiapoptotic ActionsS

Structure-based drug design identifies novel LPA sub(3) antagonists

Structure-based drug design identifies novel LPA 3 antagonists

Combined Mitigation of the Gastrointestinal and Hematopoietic Acute Radiation Syndromes by an LPA 2 Receptor-Specific Nonlipid Agonist

Suchergebnisse filtern